3003新葡的京集团
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.04.25
中天国富有限公司关于公司2017年度募集资金存放与使用情况的专项核查意见
2018.04.25
中天国富有限公司关于公司使用部分超募资金永久性补充流动资金的核查意见
2018.04.25
2017年度监事会工作报告
2018.04.25
上市公司内部控制规则落实自查表
2018.04.25
关于公司会计政策变更的公告
2018.04.25
关于使用部分超募资金永久性补充流动资金的公告
2018.04.25
关于举行2017年度报告网上说明会的公告
2018.04.25
2017年度财务决算报告
2018.04.25
关于2017年度经审计业绩与业绩快报存在差异暨董事会致歉公告
2018.04.25
2017年年度审计报告
第一页
上一页
59
60
61
62
63
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.